Metrics as of 10/13/2026, 08:54 AM (Berlin time), refresh in progress.
Stevanato Group Stock
Stevanato Group S.p.A.
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- Italy
- CEO
- Franco Stevanato
- Employees
- 6,010
- Market cap
- $5.2 B
- IPO
- 16/07/2021
Stevanato Group S.p.A. operates within the Healthcare sector and is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare industries. The company's core offerings encompass a wide array of products, including drug delivery systems, containment solutions,…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Stevanato Group stock: price history
1D
-1.8%
1W
-4.8%
1M
-9.6%
6M
+28.0%
YTD
-6.1%
1Y
-18.9%
2Y
-0.5%
5Y
-21.4%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~62% stronger price swings than usual
Ask the agents about Stevanato Group
Analyst assessment of Stevanato Group
PRICE TARGET LOW
US$17.50
CONSENSUS
US$25.58
MEDIAN
US$26.00
PRICE TARGET HIGH
US$33.00
0
STRONG BUY
5
BUY
3
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 09/09/2026
Stevanato Group stock metrics
P/E
35.17
P/B
2.97
EV/EBITDA
16.78
RETURN ON EQUITY
1.5%
NET MARGIN
7.6%
DEBT/EQUITY
0.29
DIVIDEND YIELD
0.3%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
100.0%
FLOAT SHARES
273,012,934
AVG. DAILY VOLUME (30D)
297,209
Insider transactions (SEC)
Stocchi Mauro
Magistretti Elisabetta
Dal Lago Marco
Santel Luciano
Stocchi Mauro
Institutional holders
Dividends
Comparable stocks
Frequently asked questions about Stevanato Group stock
What does Stevanato Group do?
Stevanato Group S.p.A. is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in Italy.
The CEO is Franco Stevanato, the company employs around 6,010 people.
The IPO was on 16/07/2021; the stock trades on NYSE under the ticker STVN.
What do analysts say about Stevanato Group stock?
8 analysts rate the stock, the consensus is Buy (as of 09/09/2026).
The average price target is US$25.58, ranging from US$17.50 to US$33.00, with a median of US$26.00.
This is an external assessment, not a statement by Market Jury.
When does Stevanato Group report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 62% stronger than usual.
Does Stevanato Group pay a dividend?
Yes. The last dividend was US$0.06 per share, ex-date 11/06/2026, paid on 29/07/2026.
The dividend yield is 0.3% (as of 30/06/2026).
Which stocks are comparable to Stevanato Group?
Comparable stocks include Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Sartorius, Solventum, Baxter International and Cooper Companies.
How can I get Stevanato Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Stevanato Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.